medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2014, Number 3

<< Back Next >>

Rev Esp Med Quir 2014; 19 (3)

Disorder by substance use and its relationship with attention deficit hyperactivity disorder

Aguilar-Bustos OE

Language: Spanish
References: 23
Page: 326-331
PDF size: 480.37 Kb.


ABSTRACT

Attention deficit hyperactivity disorder (ADHD) and Substance Use Disorder (SUD) are closely related; frequently the both of them appear together in the same person. ADHD and SUD share anatomical basis, in both disorders dorsolateral prefrontal cortex is affected and subcortical activity is enhanced; as a result, inhibition is reduced and reward evaluation is deficient. ADHD count as a risk factor for lifetime SUD, in this context, ADHD treatment in the early stages of life is very important. Pharmacological therapies for ADHD treatment have been tested and favorable results have been found, when stimulants are used for clinical purposes, can protect against SUD development. Cognitive skills training must be considered too for ADHD treatment in order to get better results.


REFERENCES

  1. Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med 2010;122(5):97–109.

  2. Frodl T. Comorbidity of ADHD and substance use disorder (SUD): a neuroimaging perspective. JAttenDisord 2010;14(2):109–20.

  3. Lalongoa N, McCrearyb BK, Pearsonc JL, Koeniga AL, Schmidt NB, Poduskad J, Kellamd SJ. Major depressive disorder in a population of urban, African-American young adults: prevalence, correlates, comorbidity and unmet mental health service need. Journal of Affective Disorders 2004;79:127–136.

  4. Currie SR, Patten SB, Williams JV, Wang JL, Beck CA, El-Guebaly N, Maxwell C. Comorbidity of Major Depression With Substance Use Disorders. Can J Psychiatr 2005;50:660–666.

  5. Bovasso GB, Cannabis Abuse as a Risk Factor for Depressive Symptoms. Am J Psychiatry 2001;158:2033–2037.

  6. Haynes JC, Farrel M, Singleton N, Meltzer H, Araya R, Lewis G,Wiles NJ, Consumo del alcohol como factor de riesgo para la ansiedad y la depresión. British Journal of Psychiatry 2005;187:544- 551.

  7. Levy B, Monzani BA, Stephansky MR, Weiss RD. Neurocognitive impairment in patients with co‐occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Research 2008;161(1):28–35.

  8. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006;67(2):247–257.

  9. Ralevski E, Olivera-Figueroa LA, Petrakis I. PTSD and comorbid AUD: a review of pharmacological and alternative treatment options 2014;7;5:25-36.

  10. Drake RE, Mueser KT. Co-Occurring Alcohol Use Disorder and Schizophrenia. Alcohol Research and Health 2002;26:99-102.

  11. National Institute on Drug Abuse, Comorbidity: Addiction and Other Mental Illnesses. 2010. National Institute on Drug Abuse. Disponible en: http://www.drugabuse.gov/ publications/research-reports/comorbidity-addictionother- mental-illnesses

  12. American Psychiatric Association, Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing, 2013.

  13. Bukstein O, Substance abuse in patients with attention deficit/hyperactivity disorder. Medscape J Med 2008;10:24.

  14. Jentsch JD, Taylor JR, Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 1999;146:373–390.

  15. Goldstein R Z, Volkow N D, Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002;159:1642–1652.

  16. Rutledge KJ, van den Bos W, McClure SM, Schweitzer JB. Training Cognition in ADHD: Current Findings, Borrowed Concepts, and Future Directions Neurotherapeutics 2012;9:542–558.

  17. McClure SM, Berns GS, Montague PR. Temporal prediction errors in a passive learning task activate human striatum. Neuron, 2003;38:339-346.

  18. Hare TA, Camerer CF, Rangel A. Self-control in decisionmaking involves modulation of the vmPFC valuation system. Science 2009;324:646-648.

  19. Charach A, Yeung E, Climans T, Lillie E. Childhood attentiondeficit/ hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011;50(1):9–21.

  20. Lee SS, Humphreys KL, Flory K, Liu R, Glass K Prospective Association of Childhood Attention-deficit/ hyperactivity Disorder (ADHD) and Substance Use and Abuse/ Dependence: A Meta-Analytic ReviewClinPsychol Rev 2011;31(3):328–341.

  21. Bejerot S, Ryden EM, Arlinde CM. Two-year outcome of treatment with central stimulant,medication in adult attention-deficit/hyperactivity disorder: a prospective study. J Clin Psychiatry 2010;71(12):1590–7.

  22. Wilens TE, Biederman J, Alcohol, drugs, and attentiondeficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol 2006;20:580–588.

  23. Bickel W R, Yi R, Landes R, Hill P, Baxter C, Remember the Future: Working Memory Training Decreases Delay Discounting Among Stimulant Addicts. Biol. Psychiatry 2011;69;260–265.




2020     |     www.medigraphic.com